This data brief presents findings from the 2021-2024 National Surveys on Drug Use and Health (NSDUHs) on trends in the use of selected substances among young adults aged 18 to 25 in the noninstitutionalized, civilian U.S. population.
Search Results
This data brief presents findings from the 2024 National Survey on Drug Use and Health (NSDUH) on symptoms of generalized anxiety disorder (GAD) among adults aged 18 or older in the noninstitutionalized, civilian U.S. population.
This infographic is a visual presentation of selected estimates from the 2022-2024 National Surveys on Drug Use and Health (NSDUHs) focusing on substance use and mental health indicators.
This spotlight presents estimates based on pooled data from the 2022, 2023, and 2024 NSDUH on selected mental health and substance use measures among veterans aged 18 or older who served or did not serve in a military combat zone.
This report uses pooled data from the 2022, 2023, and 2024 NSDUH to analyze sociodemographic or geographic characteristic in adults ages 18 or older who reported experiencing serious thoughts of suicide or any mental illness (AMI) in the past year.
This report uses pooled data from the 2022, 2023, and 2024 NSDUH to analyze sociodemographic or geographic characteristic in adolescents aged 12 to 17 in the past year who reported experiencing a Major Depressive Episode (MDE) or serious thoughts of suicide in the past year.
This report presents data from the NSDUH 2024 focusing on the receipt of mental health treatment in the past year among adults aged 18 or older who had any mental illness (AMI) and among adolescents aged 12 to 17 who had a major depressive episode (MDE) in that period.
This report analyzes pooled data from the 2022, 2023, and 2024 NSDUH of adults aged 18 or older and adolescents aged 12 to 17 who engaged in binge drinking in the past month.
This report analyzes pooled data from the 2022, 2023, and 2024 NSDUH from adults aged 18 or older who ever had a problem with their use of drugs or alcohol or with their mental health.
This spotlight presents annual averages for the receipt of MOUD in the past year among adults aged 18 or older who had an OUD in that period based on pooled data from the 2022, 2023, and 2024.
This report focuses on the receipt of substance use treatment in the past year among people who had a substance use disorder (SUD) in that period based on 2024 NSDUH Data.
This report explores past year marijuana use, including use of any marijuana or cannabis products in the past year, and past year opioid misuse, including misuse of heroin, prescription opioids, and/or morphine based on pooled NSDUH data from 2022, 2023, and 2024.
This report explores past year substance use disorder by population characteristics such as sex, race/ethnicity, and age based on pooled NSDUH data from 2022, 2023, and 2024.
Using pooled data from the 2022, 2023, and 2024 National Survey on Drug Use and Health (NSDUH), this report analyzes past month tobacco product use or nicotine vaping among adults aged 18 or older and adolescents aged 12 to 17.
This data brief presents findings from the 2022 and 2023 National Surveys on Drug Use and Health (NSDUHs) on illegally made fentanyl (IMF) use among the noninstitutionalized, civilian U.S. population.